196 related articles for article (PubMed ID: 25423120)
1. Feasibility study of particulate extracellular matrix (P-ECM) and left ventricular assist device (HVAD) therapy in chronic ischemic heart failure bovine model.
Soucy KG; Smith EF; Monreal G; Rokosh G; Keller BB; Yuan F; Matheny RG; Fallon AM; Lewis BC; Sherwood LC; Sobieski MA; Giridharan GA; Koenig SC; Slaughter MS
ASAIO J; 2015; 61(2):161-9. PubMed ID: 25423120
[TBL] [Abstract][Full Text] [Related]
2. Continuous-Flow Left Ventricular Assist Device Support Improves Myocardial Supply:Demand in Chronic Heart Failure.
Soucy KG; Bartoli CR; Phillips D; Giridharan GA; Sobieski MA; Wead WB; Dowling RD; Wu ZJ; Prabhu SD; Slaughter MS; Koenig SC
Ann Biomed Eng; 2017 Jun; 45(6):1475-1486. PubMed ID: 28168379
[TBL] [Abstract][Full Text] [Related]
3. Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device therapy.
Vikholm P; Schiller P; Johansson J; Hellgren L
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):625-31. PubMed ID: 23477692
[TBL] [Abstract][Full Text] [Related]
4. Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.
Gupta S; Woldendorp K; Muthiah K; Robson D; Prichard R; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Dhital K; Granger E; Spratt P; Jansz P; Hayward CS
Heart Lung Circ; 2014 Oct; 23(10):963-9. PubMed ID: 24973864
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic changes and retrograde flow in LVAD failure.
Giridharan GA; Koenig SC; Soucy KG; Choi Y; Pirbodaghi T; Bartoli CR; Monreal G; Sobieski MA; Schumer E; Cheng A; Slaughter MS
ASAIO J; 2015; 61(3):282-91. PubMed ID: 25635935
[TBL] [Abstract][Full Text] [Related]
6. Bovine model of chronic ischemic cardiomyopathy: implications for ventricular assist device research.
Bartoli CR; Sherwood LC; Giridharan GA; Slaughter MS; Wead WB; Prabhu SD; Koenig SC
Artif Organs; 2013 Dec; 37(12):E202-14. PubMed ID: 23876076
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular volume unloading with axial and centrifugal rotary blood pumps.
Giridharan GA; Koenig SC; Soucy KG; Choi Y; Pirbodaghi T; Bartoli CR; Monreal G; Sobieski MA; Schumer E; Cheng A; Slaughter MS
ASAIO J; 2015; 61(3):292-300. PubMed ID: 25635936
[TBL] [Abstract][Full Text] [Related]
8. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
Maybaum S; Mancini D; Xydas S; Starling RC; Aaronson K; Pagani FD; Miller LW; Margulies K; McRee S; Frazier OH; Torre-Amione G;
Circulation; 2007 May; 115(19):2497-505. PubMed ID: 17485581
[TBL] [Abstract][Full Text] [Related]
9. Rotary pump speed modulation for generating pulsatile flow and phasic left ventricular volume unloading in a bovine model of chronic ischemic heart failure.
Soucy KG; Giridharan GA; Choi Y; Sobieski MA; Monreal G; Cheng A; Schumer E; Slaughter MS; Koenig SC
J Heart Lung Transplant; 2015 Jan; 34(1):122-131. PubMed ID: 25447573
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Regeneration in the Human Left Ventricle After CorMatrix Implantation.
Ferng A; Connell A; Nunez M; Johnson K; Braunhut B; Lick S; Desai A; Kazui T; Runyan R; Khalpey Z
Ann Thorac Surg; 2017 Sep; 104(3):e239-e241. PubMed ID: 28838516
[TBL] [Abstract][Full Text] [Related]
11. Ventricular assist device outflow-graft site: effect on myocardial blood flow.
Tuzun E; Narin C; Gregoric ID; Cohn WE; Frazier OH
J Surg Res; 2011 Nov; 171(1):71-5. PubMed ID: 20605602
[TBL] [Abstract][Full Text] [Related]
12. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
[TBL] [Abstract][Full Text] [Related]
13. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.
Bruggink AH; van Oosterhout MF; de Jonge N; Ivangh B; van Kuik J; Voorbij RH; Cleutjens JP; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Sep; 25(9):1091-8. PubMed ID: 16962471
[TBL] [Abstract][Full Text] [Related]
14. Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling.
Mewhort HE; Turnbull JD; Meijndert HC; Ngu JM; Fedak PW
J Thorac Cardiovasc Surg; 2014 May; 147(5):1650-9. PubMed ID: 24075463
[TBL] [Abstract][Full Text] [Related]
15. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
[TBL] [Abstract][Full Text] [Related]
16. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
18. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
19. Left Ventricular Decompression During Speed Optimization Ramps in Patients Supported by Continuous-Flow Left Ventricular Assist Devices: Device-Specific Performance Characteristics and Impact on Diagnostic Algorithms.
Uriel N; Levin AP; Sayer GT; Mody KP; Thomas SS; Adatya S; Yuzefpolskaya M; Garan AR; Breskin A; Takayama H; Colombo PC; Naka Y; Burkhoff D; Jorde UP
J Card Fail; 2015 Oct; 21(10):785-91. PubMed ID: 26117282
[TBL] [Abstract][Full Text] [Related]
20. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
